Member Info for HedgeHogarth

My final post now until we hit 3p

DHub - In fairness to MMs - they are in place to make money - we should probably avoid worrying about their moves. I'm confident the SP is only going one way in the short to medium term - but buyers need sellers and when MMs drop the price it usually results in some weak hands selling. It also has gives MMs some cheaper shares that they can sell around 2.4-2.5 (the placing price) which will get snapped up quickly.

If all goes to plan - its a win -win - win for MMS, existing holders and new investors

Good luck - see you at 3p

Bline - love the bus analogy - great minds think alike 'eh :-)

One2one - you not using your blue-bottle alias today?

Unexpected dip in SP this morning - Looks like many taking the opportunity to scoop them up

#Number5(p)Bus

#Boarding

Probably a number of reasons (in order of priority)

They entered into a strategic partnership with Hemo. A cash injection (through a direct share offer) to Hemo is very important given the difficulty in raising funds in the current market. Hemo are seemingly funded now for 12-18mths. It is important to Prevail that Hemo are set-up for success.

Prevail did a thorough due diligence leaving no stone un-turned - they must have been content that the value in Hemo's portfolio of pre-clinical assets.

I also imagine that Hemo have given some assurances to Prevail as part of the deal.

I very much doubt much shorting at play. A few probably still trying to exit shorts perhaps

Too much news flow and change of sentiment for a successful short IMO

Maybe the odd brave or stupid person may try shorting.

It may be different when the SP goes to 6p - imagine a few may chance their arm with a short then.

6p is not "Off the table" - with momentum building there is a chance (IMO) that we could see 6p this month. Although a better chance of seeing 6p by the end of the year.

I think 3-4p is a more realistic expectation in the next 10 days

Although the right RNS at the right time could accelerate things here. But the timing of the next RNS is guesswork - apart from knowing we have the interim report in the next 2 weeks and almost certainly a CAR-T update this side of Xmas.

GLA

Micky - you are listening to the wrong people if you had the impression this would shoot to 6p. And letting your emotions get the better of you

However, It has been a great couple of weeks for Hemo SP - have gone from 1.48p (7th Sept) to 2.5p (19th Sept). Thats a c70% increase.

32.5m shares transacted Today; more than 29m of these were transacted at 2.5p or higher, 22m of which were traded at 2.6p or higher

I have tweeted (X'd) a graph showing the spread of trades over the last 3 days.

For me, the SP absolutely today moved forward in every way today. The only reason for it showing red and closing marginally down is due to some MMs manoeuvres.

Many investors (including me) bought north of 2.5p today; and it's not rocket science why we did that.

I'm not ramping - although i appreciate this post will come across particular;y bullish.

It's all there for everyone to see in the last 10 days

Great RNSs - Tick, Tick

Significant increase in Volume - Tick

Rising Share price - Tick

Media coverage - Tick, Tick, Tick, Tick etc

Bullish Trading sites (British Bulls, Zak Mir Bulletin Board Heroes, Vox Markets, LSE) - Tick Tick, Tick, Tick

Trolls gone awol (Tick - with the occasional appearance of a weary, poor performing One2One / Blue-Bottle)

Newsflow to come - Tick, Tick, Tick

Funded for 12-18mth - Tick

Onwards and upwards

And for balance, an 800k delayed trade has just come through that looks like a sell

Right on cue....another Big delayed buy just popped up from 11:39am - 650k @2.67p

That is hilarious - eagle eye JHFH

An easy "REPORT POST" in which this troll and manipulative poster is clearly using multiple aliases

I cannnot say whether Vlad pitched yet but the attached link would suggest he is very much at the conference to pitch CBR

https://www.linkedin.com/feed/update/urn:li:activity:7106011664025571328?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7106011664025571328%29

Note the delay in reporting of 3 BIG buys today

Don't let this tactic by MMs mislead you!

Top 7 Trades today (anything 400k+)

I think all but 1 are buys - £86k Bought, £12.5k sold

There are some substantial sells today as well today below the 400k threshold (which is healthy - buyers need sellers)

Not a surprise to LTHers - so much more news to come and mCAP still low given it's array of assets and "estimated" to be fulled funded for 12-18mths

Volume Price Time Transacted Time Reported Spread at time of Transactions Value Buy or Sell?(Guess)

450k 2.64p 11:34 11:34 2.5 – 2.65 £12k Buy (in line with Ask)

400k 2.64p 11.22 11.22 2.5 – 2.65 £10.5k Buy (in line with Ask)

766k 2.6p 10:49 11:49 2.45 – 2.6 £20k Buy (in line with Ask)

500k 2.73p 9.59 10.59 2.5 – 2.65 £13.5k Buy (at a premium to the Ask)

528k 2.5p 8:29 8:29 2.4 - 2.5 £13k Buy (in line with Ask)

473k 2.63p 8.03 8.03 2.6 - 2.7 £12.5k Sell (close to Bid and followed what was probably a Buy at the Open)

647k 2.61p 8.00 9.00 2.55 - 2.7 £17k Buy (Opening trade of the day and price above anything sold in last hour of Monday’s trading)

GLA

A quick scan of their website of what Hemo can expect:

Love the sounds of 'realtime' visibility from Day 1 and they appear to be flexible with financing. Well done Vlad and the team at Hemo - looks like the making of a great partnership for CAR-T

Prevail's proposition >>>

Are you Sponsoring or Conducting an important Clinical Trial that would RISE ABOVE with unparalleled results if you had a CRO enabling:

All data sources seamlessly integrated into a Single Interface®?

Real-time visibility from Day One?

Early indicators and readouts?

Faster outcomes and analytics?

Drill down functionality for easy analysis?

Easier accounting and budget control?

Budget percentage of completion?

Paying for your investment out of savings and efficiencies?

Gra2am - It depends what route they take. There is nothing stopping investors buy on the open market

I imagine it would be "months" if it was to follow the pattern of the Prevail one.

There will be many considerations:

- Negotiating a price

- Due Diligence by investor

- Adhering to rules on how many new shares Hemo can issue in a financial year

So I think you have answered your own question - its about the length of a piece of string,

Focus right now is

(1) Commencing clinical trials ASAP

(2) Preparing an update and agree next steps on CBR

(3) (Hopefully) Update Website ;-)

(4) Refine / Finalise Interim report (due by end of this month)

Mr India - I do share your optimism and I believe 10p is a credible target for shareholders - I believe we will see 10p by the end of next year. But it is impossible to predict when and what news will need to drop to achieve it....

- start of trials

- initial resulst of trials

- CBR update

- CDX Update

- Website Update

- Further Partnerships

- Potential TR1s?

I will slightly disagree with you that 6p only represents CAR-T. I understand that Prevail conducted very thorough due diligence on Hemogenyx ahead of making the investment. (1) As you would expect and (2) It's their job and It is a big validation for Hemo that they conducted such through checks and chose to invest at a premium,

I have no opinion on the timing. But I absolutely expect further partnerships.

It's almost inevitable. Hemo have the assets but not the resources to move 3 promising clinical candidates forward on their own.

Let's hope that yesterday's partnership deal is a taste of what's to come

GLA

Although, for me the best news was the confirmation of the timelines I'm yesterday's RNS

It's only about 12 weeks (pre Xmas) to go this year; yet the RNS stayed yesterday that Hemo expect to commence clinical trials this year.

Thats suggest they are very confident they can quickly complete the preparations following the green light from the FDA (that they have accepted Hemo plan to address clinical hold)

I'm.not sure how many and how much have shorted. We know the price of this share has seemingly been driven low in recent years.

I hope there is good amount and that a short squeeze could be on....

I dropped Dr Sandler a note lat night to congratulate Hemo on it's excellent news and how well received it was on the market.

I also was curious how bos pitch went yesterday. However, he did not share anything as expected as it could be considered price sensitive.

He said Hemo had been working on the strategic partnership and conversations about the investment in Hemo for a while. He was very pleased that their were no leaks and it landed as a surprise. (Although they had shared with market that they are in multiple conversations with partners)

His parting words were encouraging though...

"Stay tuned for further developments, we work harder than ever"

Hopefully the next partnership development will be with CDX. And as I have shared before, many believe a CBR update must be due soon following the great RNS I'm January

Good luck all

There is no need to try and mislead anyone as a shareholders.

Sticking to the facts is more than compelling